Wegovy Private Pay: What the Process Looks Like and What You Pay

Step 1: Complete a clinical consultation, this is not optional paperwork

The first thing anyone considering private Wegovy needs to understand is that the consultation is where treatment either starts or doesn't. Semaglutide is a Prescription Only Medicine under UK law, which means no consultation means no prescription and no medicine, full stop. That applies to every provider, not just nume.

At a regulated online pharmacy such as nume, the consultation is free and structured: you provide your medical history, current medications, weight and BMI, and answer questions about relevant conditions. Identity is verified with photo ID, and weight is confirmed on video, not taken on trust. Once submitted, a GPhC-registered Independent Prescriber reviews everything personally. It is not software making the call; a named clinician reads your file the same day.

If treatment is approved, a prescription is generated. If it is not, you will be told why and pointed toward alternatives. That honest gate matters more for a POM than for almost any other product. You can read more about how our clinical team approaches these decisions on the clinical team page.

One thing worth clearing up gently: many people assume private prescriptions work like buying over-the-counter supplements. They don't. The clinical assessment is exactly the same standard whether the prescription is NHS or private; what differs is who funds it and how quickly you can access the service.

Step 2: Understand what the dose ladder means for your monthly cost

Wegovy's licensed schedule starts at 0.25 mg weekly and increases approximately every four weeks, through 0.5 mg, 1.0 mg, 1.7 mg and up to 2.4 mg, with 7.2 mg now also approved by the MHRA as a higher maintenance option for eligible adults with obesity. Because each dose level corresponds to a different pen, what you pay per month shifts as treatment progresses. The starter pens are generally less expensive than the higher doses.

This is one reason a single headline price can be misleading. A provider quoting a low figure may be quoting the 0.25 mg starter cost; the figure that applies for most of treatment is the maintenance-dose cost. If you want a clear picture of how those numbers stack up across the titration schedule, the monthly private cost breakdown covers each stage in detail.

Private costs reported across the UK market since late 2025 typically range from roughly £149 to £375 per month depending on dose and provider, though figures vary and should be treated as a guide rather than a guarantee. If you are researching how much Wegovy costs privately, it is worth reading beyond the starter-dose figure to understand what you are likely to pay at maintenance. The UK provider comparison sets out the landscape factually so you can make an informed judgement. At nume, one transparent price covers everything (consultation, prescription, the medicine, and free next-working-day delivery) with no subscription and no hidden add-ons. Current Wegovy pricing at nume is shown on the treatment page.

NICE's guidance on semaglutide for weight management, published as Technology Appraisal TA875, sets out the clinical criteria against which prescribers assess suitability; private providers work within those same clinical parameters even where NHS access conditions differ.

Step 3: Factor in what ongoing private pay actually involves

Private pay is not a one-off purchase. Wegovy is a long-term treatment, and responsible private prescribing means clinical review before every repeat order, not an auto-renewal that sends the next pen without checking in. At nume, no repeat is issued without a prescriber re-assessing your progress. That is a deliberate safety position, not an inconvenience.

What this means practically: before each new supply, you confirm how treatment is going, report any side effects, and check that your dose remains appropriate. This regular touchpoint is where prescribers catch problems early and where dose adjustments are agreed. The Wegovy treatment guide covers what those check-ins typically look at.

Side effects to be aware of over the course of treatment are largely gastrointestinal, nausea is most common, especially in the first weeks of a new dose. Constipation, reflux and fatigue also feature. Most settle as the body adjusts. For anyone experiencing severe or persistent abdominal pain that spreads to the back, stopping and seeking medical attention promptly is important; the MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines. The NHS patient information for semaglutide is a reliable first reference for the full side-effect picture: NHS semaglutide medicines page.

For a broader look at what private versus NHS routes look like across different budgets, the private cost overview breaks down the trade-offs clearly. If you would like a full breakdown of the Wegovy UK private price across providers and dose stages, that page sets out the detail before you commit to anything. When you are ready to discuss your own situation with a prescriber, the free consultation is the place to start.